Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer (the tnAcity study): study protocol for a randomized controlled trial

Yardley, D.A., Brufsky, A., Coleman, R.E. orcid.org/0000-0002-4275-1043 et al. (10 more authors) (2015) Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer (the tnAcity study): study protocol for a randomized controlled trial. Trials, 16. 575. ISSN 1745-6215

Abstract

Metadata

Authors/Creators:
  • Yardley, D.A.
  • Brufsky, A.
  • Coleman, R.E. ORCID logo https://orcid.org/0000-0002-4275-1043
  • Conte, P.F.
  • Cortes, J.
  • Glueck, S.
  • Nabholtz, J.-M.A.
  • O'Shaughnessy, J.
  • Beck, R.M.
  • Ko, A.
  • Renschler, M.F.
  • Barton, D.
  • Harbeck, N.
Copyright, Publisher and Additional Information: © 2016 Yardley et al. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Keywords: tnAcity; Triple-negative breast cancer; Metastatic; Nab-paclitaxel; Abraxane; Gemcitabine; Carboplatin; Pick-the-winner trial design
Dates:
  • Published: 16 December 2015
  • Published (online): 16 December 2015
  • Accepted: 3 December 2015
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology (Sheffield)
The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 03 Aug 2016 15:36
Last Modified: 15 Nov 2016 18:00
Published Version: http://www.doi.org/10.1186/s13063-015-1101-7
Status: Published
Publisher: BioMed Central
Refereed: Yes
Identification Number: https://doi.org/10.1186/s13063-015-1101-7
Related URLs:

Share / Export

Statistics